scholarly journals EFFECT OF PANCHKARMA IN MYASTHENIA GRAVIS: A CASE REPORT

2020 ◽  
Vol 8 (7) ◽  
pp. 4003-4008
Author(s):  
Atul Joshi ◽  
Amit Awadhiya ◽  
Neha Keshari ◽  
Anup Thakar
Keyword(s):  
Skeletal Muscle ◽  
Case Report ◽  
Side Effects ◽  
Myasthenia Gravis ◽  
Neuromuscular Disease ◽  
Acetylcholine Receptors ◽  
Present Observation ◽  
Autoimmune Attack ◽  
Skeletal Muscle Weakness

Myasthenia Gravis (MG) is a long-term neuromuscular disease that leads to varying degrees of skeletal muscle weakness. The condition is caused by breakdown in communication between nerves and muscles. The underlying defect is a decrease in the number of available acetylcholine receptors (AChRs) at neuro-muscular junctions due to an antibody mediated autoimmune attack.1 The most commonly affected mus-cles are those of the eyes, face and swallowing. The cause of this disease can be understood in view of Dhatavgnimaandhya, Vyana Vayu Vikriti. The present observation was conducted with an objective to find out the efficacy of Ayurvedic management in Myasthenia Gravis. Here is a case of 60 years old Hindu male who was diagnosed as Myasthenia Gravis (MG) reported with complaint of slurred speech, low pitch of voice, difficulty to open the mouth and to swallow food and difficulty in elevating right eyebrow since 6 months was registered in OPD of Panchakarma, IPGT & RA, Jamnagar. Considering the signs and symp-toms patient was treated on the line of Aavrita Vata Chikitsa, Sthanika Abhyanga with Bala Taila, Nasya with Anu Taila, Jihwa Pratisarana with Vacha Churna and Ghritapana before meal with Go Ghrita was administered. Treatment shows significant improvement in the symptoms without any side effects.

Long-term side effects following pneumonectomy: A case report and review of the literature

2019 ◽  
Author(s):  
BA Högerle ◽  
EL Bulut ◽  
L Klotz ◽  
F Eichhorn ◽  
M Eichhorn ◽  
...  
Keyword(s):  
Case Report ◽  
Side Effects ◽  
Review Of The Literature

scholarly journals AN AYURVEDIC CASE REPORT ON AMYOTROPHIC LATERAL SCLEROSIS

2021 ◽  
Vol 9 (11) ◽  
pp. 2903-2908
Author(s):  
Ambika. K ◽  
Arundhathi. K ◽  
Lekshmi G. Krishna
Keyword(s):  
Quality Of Life ◽  
Skeletal Muscle ◽  
Amyotrophic Lateral Sclerosis ◽  
Case Report ◽  
Lower Limbs ◽  
Skeletal Muscle Weakness ◽  
Treatment Principle ◽  
Severe Type ◽  
Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a common and most severe type of Motor Neuron Disease. It is characterized by progressive skeletal muscle weakness, wasting and fasciculations. Survival is for 3-5 years, and the death is from respiratory paralysis. The incidence of ALS is between 0.6 and 3.8 per 100000 persons per year. Males are predominantly affected. Here is a case report of 45yrs old male who presented with complaints of difficulty in walking since 3years, with an insidious asymmetric onset of weakness of bilateral lower limbs with wasting and fasciculations. In Ayurveda, the case was symptomatologically diagnosed as Mamsa Sosha, which occurs as the result of obstruction of Snayu and Rakthadhamanis (Mamsavaha srotomoolas). The assessment was done using ALSFRS-R Scale. The treatment was aimed at improving the quality of life and also decreasing the rate of disease progression. The treatment principle adopted was Srothosodhana (Ama- Avaranaghna cikitsa) and Brimhana. Promising results were obtained after treatment. Keywords: ALS, MND, Ayurveda, Avaranaghna cikitsa, Mamsa Sosha, Mamsa Kshaya

scholarly journals Acute onset clozapine-induced hyperglycaemia: A case report

2019 ◽  
Vol 32 (2) ◽  
pp. e100045 ◽  
Author(s):  
Pradeep Kumar ◽  
Dheerendra Kumar Mishra ◽  
Nimisha Mishra ◽  
Sunil Ahuja ◽  
Gyanendra Raghuvanshi ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Case Report ◽  
Side Effects ◽  
Atypical Antipsychotic ◽  
Time Frame ◽  
Acute Onset ◽  
Antipsychotic Medications ◽  
Pathophysiological Mechanisms ◽  
Hypoglycaemic Agent

Clozapine is an atypical antipsychotic which is described to have higher efficacy among all available antipsychotic medications. Clozapine is reserved especially for resistant schizophrenia due to its side effects. Clozapine-induced metabolic syndrome and hyperglycaemia are common long-term side effects and are responsible for increased mortality in patients with schizophrenia. In this case, a patient with resistant schizophrenia was presented with acute-onset hyperglycaemia and delirium with the use of clozapine within a week. Withdrawal of clozapine in the patient led to the improvement in delirium and hyperglycaemia without the use of any hypoglycaemic agent. This case supports the notion that in certain cases clozapine can induce hyperglycemia through possible direct pathophysiological mechanisms within a shorter time frame.

Long-term effects of cancer therapy on dental development: a case report

2004 ◽  
Vol 28 (4) ◽  
pp. 351-353 ◽  
Author(s):  
Sedat Cetiner ◽  
Cansu Alpaslan
Keyword(s):  
Case Report ◽  
Side Effects ◽  
Cancer Therapy ◽  
Dental Development ◽  
Long Term Effects ◽  
Antineoplastic Treatment ◽  
Malignant Condition

As the prognosis of malignant conditions in children improve by cancer therapy, long-term side effects due to antineoplastic treatment may be encountered. This case report demonstrates the long-term alterations on dental development in patient who had been treated for malignant condition. Alterations were observed during radiographic control 8 years after the therapy and included short, blunted, tapered and V-shaped root malformations as well as delayed and ectopic eruptions.

scholarly journals Thymic B lymphocyte clones from patients with myasthenia gravis secrete monoclonal striational autoantibodies reacting with myosin, alpha actinin, or actin.

1986 ◽  
Vol 164 (4) ◽  
pp. 1043-1059 ◽  
Author(s):  
C L Williams ◽  
V A Lennon
Keyword(s):  
Skeletal Muscle ◽  
Epithelial Cells ◽  
Myasthenia Gravis ◽  
Nicotinic Acetylcholine Receptors ◽  
Acetylcholine Receptors ◽  
B Lymphocyte ◽  
High Yield ◽  
Thymic Epithelial Cells ◽  
Anchoring Proteins ◽  
Mucosal Cells

Striational autoantibodies (StrAb), which react with elements of skeletal muscle cross-striations, occur frequently in patients with thymoma associated with myasthenia gravis (MG). Dissociated thymic lymphocytes from 22 of 72 MG patients secreted StrAb when cultured with PWM. A high yield of EBV-transformed B cell lines was established from thymus, thymoma, and peripheral blood of seven patients with MG, but clones secreting StrAb arose only from the three patients who had StrAb in their sera. The monoclonal StrAb bound to A bands or I bands in skeletal muscle of human, rat, and frog. One bound to mitochondria in addition to myofibrillar I bands. None bound to nuclei, smooth muscle, or gastric mucosal cells. In immunoblot analyses and ELISAs the monoclonal StrAb bound to muscle and nonmuscle isotypes of myosin, alpha actinin, and/or actin. All bound to contractile proteins common to thymus and muscle, and one selectively immunostained epithelial cells of the thymic medulla. From these antigenic specificities we suggest that StrAb might arise as an immune response directed against the cytoskeletal anchoring proteins associated with nicotinic acetylcholine receptors in thymic epithelial cells undergoing neoplastic transformation to thymoma.

Heart Failure Without Subjective Skeletal Muscle Weakness in Becker Muscular Dystrophy Patient: A Case Report

2014 ◽  
Vol 20 (10) ◽  
pp. S202-S203
Author(s):  
Toshiyuki Ohya ◽  
Mahoto Kato ◽  
Kazuhito Tohyama ◽  
Yasuo Okumura ◽  
Tadateru Takayama ◽  
...  
Keyword(s):  
Heart Failure ◽  
Skeletal Muscle ◽  
Case Report ◽  
Muscular Dystrophy ◽  
Muscle Weakness ◽  
Becker Muscular Dystrophy ◽  
Skeletal Muscle Weakness

scholarly journals Muscle-Specific Tyrosine Kinase-Associated Myasthenia Gravis: A Neuromuscular Surprise

2021 ◽  
Vol 2021 ◽  
pp. 1-3
Author(s):  
Hassam Ali ◽  
Rahul Pamarthy ◽  
Nayab Ahsan ◽  
WashmaAwan ◽  
Shiza Sarfraz
Keyword(s):  
Neuromuscular Junction ◽  
Tyrosine Kinase ◽  
Myasthenia Gravis ◽  
Muscle Weakness ◽  
Acetylcholine Receptors ◽  
Muscular Contraction ◽  
Skeletal Muscle Weakness ◽  
Hypoxic Respiratory Failure ◽  
Receptor Antibodies

Myasthenia gravis is a neuromuscular autoimmune disease that results in skeletal muscle weakness that worsens after periods of activity and improves after rest. Myasthenia gravis means “grave (serious), muscle weakness.” Although not completely curable, it can be managed well with a relatively high quality of life and expectancy. In myasthenia gravis, antibodies against the acetylcholine receptors at the neuromuscular junction interfere with regular muscular contraction. Although most commonly caused by antibodies to the acetylcholine receptor, antibodies against MuSK (muscle-specific kinase) protein can also weaken transmission at the neuromuscular junction. Muscle-specific tyrosine kinase myasthenia gravis (MuSK-Ab MG) is a rare subtype of myasthenia gravis with distinct pathogenesis and unique clinical features. Diagnosis can be challenging due to its atypical presentation as compared to seropositive myasthenia gravis. It responds inconsistently to steroids, but plasma exchange and immunosuppressive therapies have shown promising results. We report a case of a 49-year-old female who presented with acute hypoxic respiratory failure. Our patient experienced progressive, undiagnosed MuSK-Ab MG for years without a diagnosis.

Single Donor Plasma in Therapeutic Plasma Exchange for Myasthenia Gravis

1987 ◽  
Vol 10 (5) ◽  
pp. 315-318 ◽  
Author(s):  
R. Mantegazza ◽  
E. Bruzzone ◽  
B. Regi ◽  
D. Peluchetti ◽  
M. Marconi ◽  
...  
Keyword(s):  
Side Effects ◽  
Myasthenia Gravis ◽  
Plasma Exchange ◽  
Optimal Schedule ◽  
Therapeutic Plasma Exchange ◽  
Single Donor ◽  
Short And Long Term ◽  
Donor Plasma

Thirty-seven myasthenic patients were treated with therapeutic plasma exchange (TPE) on different performance schedules using either random or single donor plasma. The two schedules had the same effects in terms of efficacy but single donor replacement gave significantly less side effects in the short and long term. A two exchange procedure on alternate days associated with immunosuppression seems to be an optimal schedule for the treatment of myasthenic patients. A single donor two-exchange on alternate days procedure appears to be safe, useful and can be repeated in patients who need frequent TPE.

Sign in / Sign up

Export Citation Format

Share Document